Tatsunori Toida
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tatsunori Toida has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
- Noriaki Kurita
Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University, Fukushima City, Japan
10 shared publications - Ryohei Inanaga
Department of Nephrology, Shin-Yurigaoka General Hospital, Kawasaki, Japan
9 shared publications Shouichi Fujimoto
Department of Hemovascular Medicine and Artificial Organs, Faculty of Medicine, University of Miyazaki, Miyazaki City, Japan
8 shared publicationsKazuo Kitamura
Department of Nephrology, University of Miyazaki Hospital, Miyazaki, Japan
7 shared publications- Yuji Sato
Department of Hematology and Oncology, Tsukuba Memorial Hospital, 1187-299 Kaname, Tsukuba, Ibaraki 300-2622, Japan
7 shared publications Atsuro Kawaji
Department of Nephrology, Kameda Medical Center, Chiba, Japan
6 shared publications
Latest Publications
- Open Access
- 26 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1825-1834
Association of Formal and Informal Advance Care Planning with Multidimensional Health Literacy in Patients Undergoing Hemodialysis
Key Points: Higher critical health literacy was associated with informal advance care planning, while higher total health literacy was associated with both informal and formal advance care planning in patients receiving hemodialysis. Patients unsure about treatment preferences had lower total health literacy, and lack of opportunity was the most common barrier to advance care planning engagement. Enhancing health literacy and providing structured opportunities for advance care planning may support patient-centered decision making in dialysis care. Background: Although qualitative studies suggest that health literacy (HL) may influence engagement in advance care planning (ACP) among patients undergoing dialysis, this association has not been quantitatively examined. We investigated whether multidimensional HL is associated with participation in informal and formal ACP and end-of-life care preferences. Methods: This multicenter cross-sectional study included adult patients receiving hemodialysis from six facilities in Japan. Participation in informal and formal ACP was assessed using a questionnaire, and HL was measured with the Functional, Communicative, and Critical Health Literacy scale. Associations between HL and ACP participation were analyzed using logistic regression models. We also examined patients' end-of-life care preferences in the event of serious future health deterioration. Results: Among 651 eligible patients, 466 were included in the analysis (median age, 71 years; 35% women). Informal ACP participation was reported by 52% of patients, whereas formal ACP participation was 5%. Higher critical HL was independently associated with informal ACP participation (odds ratio [OR], 1.93; 95% confidence interval [CI], 1.25 to 3.00), while higher total HL was associated with formal ACP participation (OR, 4.18; 95% CI, 1.63 to 10.77). Women and diabetes were associated with informal ACP and female sex with formal ACP. Patients who reported being unsure about future treatment preferences had lower total HL and were younger (total HL: OR, 0.63; 95% CI, 0.42 to 0.95; age: OR, 0.79; 95% CI, 0.66 to 0.95). The most common reason for not engaging in ACP discussions was a lack of opportunity to discuss ACP (71/151). Conclusions: Critical HL was associated with informal ACP participation, whereas total HL was associated with formal ACP among patients undergoing hemodialysis. In addition, the most frequently reported barrier to ACP engagement was a lack of opportunity for discussion, highlighting the need to both enhance HL and establish structured opportunities for ACP to support patient-centered decision making.
- 26 May 2026
- Published by Wolters Kluwer Health in Kidney360
- Vol. 7 (8) , 1825-1834
Open AccessAssociation of Formal and Informal Advance Care Planning with Multidimensional Health Literacy in Patients Undergoing Hemodialysis
Key Points: Higher critical health literacy was associated with informal advance care planning, while higher total health literacy was associated with both informal and formal advance care planning in patients receiving hemodialysis. Patients unsure about treatment preferences had lower total health literacy, and lack of opportunity was the most common barrier to advance care planning engagement. Enhancing health literacy and providing structured opportunities for advance care planning may support patient-centered decision making in dialysis care. Background: Although qualitative studies suggest that health literacy (HL) may influence engagement in advance care planning (ACP) among patients undergoing dialysis, this association has not been quantitatively examined. We investigated whether multidimensional HL is associated with participation in informal and formal ACP and end-of-life care preferences. Methods: This multicenter cross-sectional study included adult patients receiving hemodialysis from six facilities in Japan. Participation in informal and formal ACP was assessed using a questionnaire, and HL was measured with the Functional, Communicative, and Critical Health Literacy scale. Associations between HL and ACP participation were analyzed using logistic regression models. We also examined patients' end-of-life care preferences in the event of serious future health deterioration. Results: Among 651 eligible patients, 466 were included in the analysis (median age, 71 years; 35% women). Informal ACP participation was reported by 52% of patients, whereas formal ACP participation was 5%. Higher critical HL was independently associated with informal ACP participation (odds ratio [OR], 1.93; 95% confidence interval [CI], 1.25 to 3.00), while higher total HL was associated with formal ACP participation (OR, 4.18; 95% CI, 1.63 to 10.77). Women and diabetes were associated with informal ACP and female sex with formal ACP. Patients who reported being unsure about future treatment preferences had lower total HL and were younger (total HL: OR, 0.63; 95% CI, 0.42 to 0.95; age: OR, 0.79; 95% CI, 0.66 to 0.95). The most common reason for not engaging in ACP discussions was a lack of opportunity to discuss ACP (71/151). Conclusions: Critical HL was associated with informal ACP participation, whereas total HL was associated with formal ACP among patients undergoing hemodialysis. In addition, the most frequently reported barrier to ACP engagement was a lack of opportunity for discussion, highlighting the need to both enhance HL and establish structured opportunities for ACP to support patient-centered decision making.
- 18 May 2026
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 30 (8) , 1169-1178
Renal function and comprehensive frailty in community-dwelling older adults: cross-sectional and longitudinal analyses
Chronic kidney disease is common older adults, yet its role in overall frailty remains unclear, particularly when assessed using the Questionnaire for Medical Checkup of Old-Old (QMCOO). This study investigated both cross-sectional and longitudinal links between renal function and multidomain frailty in community-dwelling older adults. We analyzed data from 4621 participants (mean age: 80.1 years; men:39.5%) who underwent health checkups in Nobeoka City, Japan (April 2020 to March 2021). Renal function was assessed using estimated glomerular filtration rate (eGFR) and grouped as ≥ 60, 45-59, 30-44, and < 30 mL/min/1.73 m2. Multidomain frailty was defined as a QMCOO score ≥ 4 and included physical, oral, nutritional, cognitive, and social domains. For longitudinal analysis, 2398 participants without frailty at baseline were followed for 1 year; incident frailty was evaluated using logistic regression. Frailty prevalence increased as renal function declined (21.5%, 23.2%, 32.8%, and 38.7% across eGFR groups). Similar patterns were observed for physical, oral, nutritional, and cognitive domains, but not for social frailty. Over 1 year, participants with eGFR < 30 had a higher risk of developing frailty than those with eGFR ≥ 60 (adjusted odds ratio 2.37; 95% confidence interval [CI] 1.10-5.20). Declined kidney function was independently associated with both higher prevalence and incidence of comprehensive frailty, particularly in physical, oral, nutritional, and cognitive domains. Preserving renal function may help reduce frailty risk in older adults.
- 18 May 2026
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 30 (8) , 1169-1178
Renal function and comprehensive frailty in community-dwelling older adults: cross-sectional and longitudinal analyses
Chronic kidney disease is common older adults, yet its role in overall frailty remains unclear, particularly when assessed using the Questionnaire for Medical Checkup of Old-Old (QMCOO). This study investigated both cross-sectional and longitudinal links between renal function and multidomain frailty in community-dwelling older adults. We analyzed data from 4621 participants (mean age: 80.1 years; men:39.5%) who underwent health checkups in Nobeoka City, Japan (April 2020 to March 2021). Renal function was assessed using estimated glomerular filtration rate (eGFR) and grouped as ≥ 60, 45-59, 30-44, and < 30 mL/min/1.73 m2. Multidomain frailty was defined as a QMCOO score ≥ 4 and included physical, oral, nutritional, cognitive, and social domains. For longitudinal analysis, 2398 participants without frailty at baseline were followed for 1 year; incident frailty was evaluated using logistic regression. Frailty prevalence increased as renal function declined (21.5%, 23.2%, 32.8%, and 38.7% across eGFR groups). Similar patterns were observed for physical, oral, nutritional, and cognitive domains, but not for social frailty. Over 1 year, participants with eGFR < 30 had a higher risk of developing frailty than those with eGFR ≥ 60 (adjusted odds ratio 2.37; 95% confidence interval [CI] 1.10-5.20). Declined kidney function was independently associated with both higher prevalence and incidence of comprehensive frailty, particularly in physical, oral, nutritional, and cognitive domains. Preserving renal function may help reduce frailty risk in older adults.
- 1 March 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (2) , 353-363
Prevalence of financial toxicity and its association with medication adherence among patients undergoing haemodialysis under comprehensive public support in Japan
Background: Beyond affordability, financial strain can induce psychological stress and a sense of financial distress, collectively termed “financial toxicity”. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of financial toxicity and its effects on medication adherence. This study aimed to assess the prevalence of financial toxicity and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods: This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. Financial toxicity and self-reported medication adherence were assessed using the Comprehensive Score for Financial Toxicity (COST) and the 12-item Adherence Starts with Knowledge (ASK-12) scale, respectively. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. A mediation analysis was conducted to explore potential pathways underlying this association. Results: In total, 455 participants were included. The mean COST score was 22.0, and 68.5% of the participants experienced at least mild financial toxicity. Financial toxicity severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower financial toxicity (higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = −.17). The mediation analysis suggested that emotional impact represents one pathway linking financial toxicity to adherence difficulties. Conclusions: Despite generous public coverage, financial toxicity is common among Japanese patients undergoing haemodialysis and is associated with subjective difficulties in medication adherence.
- 1 March 2026
- Published by Oxford University Press (OUP) in Journal Of Nephrology
- Vol. 39 (2) , 353-363
Prevalence of financial toxicity and its association with medication adherence among patients undergoing haemodialysis under comprehensive public support in Japan
Background: Beyond affordability, financial strain can induce psychological stress and a sense of financial distress, collectively termed “financial toxicity”. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of financial toxicity and its effects on medication adherence. This study aimed to assess the prevalence of financial toxicity and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods: This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. Financial toxicity and self-reported medication adherence were assessed using the Comprehensive Score for Financial Toxicity (COST) and the 12-item Adherence Starts with Knowledge (ASK-12) scale, respectively. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. A mediation analysis was conducted to explore potential pathways underlying this association. Results: In total, 455 participants were included. The mean COST score was 22.0, and 68.5% of the participants experienced at least mild financial toxicity. Financial toxicity severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower financial toxicity (higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = −.17). The mediation analysis suggested that emotional impact represents one pathway linking financial toxicity to adherence difficulties. Conclusions: Despite generous public coverage, financial toxicity is common among Japanese patients undergoing haemodialysis and is associated with subjective difficulties in medication adherence.
- 23 November 2025
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 80 (1) , 222-229
Effect of pre- and postprandial administration of Maoto extract granules on the pharmacokinetics of ephedrine and pseudoephedrine in healthy adults
Kampo medicines are widely co-prescribed with Western drugs, yet package inserts typically recommend preprandial dosing. This convention can complicate co-medication schedules and may reduce adherence, while human pharmacokinetic (PK) evidence on meal-timing effects remains limited. We compared pre- versus postprandial administration of maoto to quantify effects on absorption rate and extent for ephedrine and pseudoephedrine. In a two-period, two-sequence crossover, eight healthy adults received ethical maoto extract granules (2.5 g) 30 min before or after a standardized meal. Plasma ephedrine and pseudoephedrine were measured by LC–MS/MS through 24 h. PK was characterized by non-compartmental analysis (NCA) and a pre-specified one-compartment absorption model. The absorption rate constant (ka) was the mechanistic primary endpoint; AUC quantified extent. Sensitivity (male-only; leave-one-out) and crossover diagnostics (sequence/period) were conducted, and model adequacy was compared by modified Akaike’s Information Criterion (AICc). Preprandial dosing yielded higher Cmax, shorter Tmax, and larger ka for both analytes, indicating faster absorption. In contrast, AUC0–24 h and model-based AUC∞ were similar between conditions, and ke did not differ, indicating unchanged extent and disposition. Sensitivity analyses supported these findings; no sequence or period effects were detected. AICc distributions were comparable between conditions. Meal timing primarily alters the absorption rate of ephedrine/pseudoephedrine from maoto without materially changing overall exposure. Preprandial dosing may be preferred when rapid onset is desired, whereas postprandial dosing remains reasonable when adherence and co-medication scheduling are prioritized. Graphical abstract
- 23 November 2025
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 80 (1) , 222-229
Effect of pre- and postprandial administration of Maoto extract granules on the pharmacokinetics of ephedrine and pseudoephedrine in healthy adults
Kampo medicines are widely co-prescribed with Western drugs, yet package inserts typically recommend preprandial dosing. This convention can complicate co-medication schedules and may reduce adherence, while human pharmacokinetic (PK) evidence on meal-timing effects remains limited. We compared pre- versus postprandial administration of maoto to quantify effects on absorption rate and extent for ephedrine and pseudoephedrine. In a two-period, two-sequence crossover, eight healthy adults received ethical maoto extract granules (2.5 g) 30 min before or after a standardized meal. Plasma ephedrine and pseudoephedrine were measured by LC–MS/MS through 24 h. PK was characterized by non-compartmental analysis (NCA) and a pre-specified one-compartment absorption model. The absorption rate constant (ka) was the mechanistic primary endpoint; AUC quantified extent. Sensitivity (male-only; leave-one-out) and crossover diagnostics (sequence/period) were conducted, and model adequacy was compared by modified Akaike’s Information Criterion (AICc). Preprandial dosing yielded higher Cmax, shorter Tmax, and larger ka for both analytes, indicating faster absorption. In contrast, AUC0–24 h and model-based AUC∞ were similar between conditions, and ke did not differ, indicating unchanged extent and disposition. Sensitivity analyses supported these findings; no sequence or period effects were detected. AICc distributions were comparable between conditions. Meal timing primarily alters the absorption rate of ephedrine/pseudoephedrine from maoto without materially changing overall exposure. Preprandial dosing may be preferred when rapid onset is desired, whereas postprandial dosing remains reasonable when adherence and co-medication scheduling are prioritized. Graphical abstract
- Open Access
Prevalence of Financial Toxicity and Its Association with Medication Adherence Among Patients Undergoing Haemodialysis Under Comprehensive Public Support in Japan
Background and hypothesis Financial toxicity (FT) refers not only to the difficulty in affording medical care but also to the psychological distress and perceived financial burden it imposes. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of FT and its effects on medication adherence. This study aimed to assess the prevalence of FT and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. FT was assessed using the Comprehensive Score for Financial Toxicity (COST), and medication adherence was assessed using the 12-item Adherence Starts with Knowledge (ASK-12) scale. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. Results In total, 455 participants were included in the analysis. The mean COST score was 22.0, and 68% of the participants experienced at least mild FT. FT severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower FT (i.e., higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = –0.19). This association was particularly evident in the ‘inconvenience/forgetfulness’ and ‘behaviour’ subdomains (per 1-point higher: β = –0.06 and β = –0.08, respectively). Conclusions Despite generous public coverage, FT is common among Japanese patients undergoing haemodialysis and is associated with difficulties in medication adherence. The awareness of hidden financial distress and its integration into shared decision-making regarding prescriptions may help improve treatment adherence and patient outcomes. What was known Among patients undergoing dialysis, medication adherence rates are generally < 70%. ‘Financial toxicity’ is associated with poor medication adherence in oncology. However, among patients undergoing dialysis receiving publicly funded care, the prevalence of financial toxicity and its effects on medication adherence remain unclear. This study adds Despite Japan’s comprehensive public insurance system, approximately 70% of patients undergoing dialysis experience at least mild financial toxicity levels, comparable to those observed in Japanese patients with cancer. Lower financial toxicity was associated with better medication adherence, particularly in the ‘inconvenience/forgetfulness’ and ‘behaviour’ subdomains. Potential impact Financial hardship can cause stress. Healthcare providers should build trust with their patients and foster open discussions on financial and social challenges. Practising shared decision-making is essential for prescribing medications that consider patients’ financial burden. Providing work-friendly dialysis schedules may support patients’ long-term financial independence.
Open AccessPrevalence of Financial Toxicity and Its Association with Medication Adherence Among Patients Undergoing Haemodialysis Under Comprehensive Public Support in Japan
Background and hypothesis Financial toxicity (FT) refers not only to the difficulty in affording medical care but also to the psychological distress and perceived financial burden it imposes. Although dialysis in Japan is extensively covered by public insurance, little is known about the prevalence of FT and its effects on medication adherence. This study aimed to assess the prevalence of FT and examine its association with medication adherence among patients undergoing haemodialysis in Japan. Methods This multicentre, cross-sectional study included Japanese adults undergoing in-centre haemodialysis at six facilities. FT was assessed using the Comprehensive Score for Financial Toxicity (COST), and medication adherence was assessed using the 12-item Adherence Starts with Knowledge (ASK-12) scale. The COST scores were compared with published data from Japanese patients with cancer and patients undergoing dialysis from other countries using unpaired t-tests. Associations between the COST and ASK-12 scores were analysed using multivariate general linear models. Results In total, 455 participants were included in the analysis. The mean COST score was 22.0, and 68% of the participants experienced at least mild FT. FT severity was comparable to that of Japanese patients with cancer and significantly lower than that reported among patients undergoing dialysis in Brazil and China. Lower FT (i.e., higher COST scores) was associated with fewer medication adherence difficulties (per 1-point higher: β = –0.19). This association was particularly evident in the ‘inconvenience/forgetfulness’ and ‘behaviour’ subdomains (per 1-point higher: β = –0.06 and β = –0.08, respectively). Conclusions Despite generous public coverage, FT is common among Japanese patients undergoing haemodialysis and is associated with difficulties in medication adherence. The awareness of hidden financial distress and its integration into shared decision-making regarding prescriptions may help improve treatment adherence and patient outcomes. What was known Among patients undergoing dialysis, medication adherence rates are generally < 70%. ‘Financial toxicity’ is associated with poor medication adherence in oncology. However, among patients undergoing dialysis receiving publicly funded care, the prevalence of financial toxicity and its effects on medication adherence remain unclear. This study adds Despite Japan’s comprehensive public insurance system, approximately 70% of patients undergoing dialysis experience at least mild financial toxicity levels, comparable to those observed in Japanese patients with cancer. Lower financial toxicity was associated with better medication adherence, particularly in the ‘inconvenience/forgetfulness’ and ‘behaviour’ subdomains. Potential impact Financial hardship can cause stress. Healthcare providers should build trust with their patients and foster open discussions on financial and social challenges. Practising shared decision-making is essential for prescribing medications that consider patients’ financial burden. Providing work-friendly dialysis schedules may support patients’ long-term financial independence.
- Open Access
Impact of Dialysis Duration and Frailty on Frailty Progression: A Japanese Nationwide Cohort Study
Importance Frailty is common among dialysis patients and significantly affects the quality of life for both patients and their caregivers. However, limited evidence exists on the long- term changes in physical function in this population. Objective To examine 8-year trajectories of physical function and assess associations with baseline dialysis duration and physical function status among Japanese dialysis patients. Design Nationwide, cohort study. Setting Japan; data obtained from a registry. Participants 223,501 Japanese adults receiving hemodialysis enrolled in the 2010 Japanese Society for Dialysis Therapy Renal Data Registry. Exposures Baseline dialysis duration (Main Outcomes and Measures Physical function at 8 years was similarly classified as non- frail, frail, bedridden, or deceased. Multinomial logistic regression was used to estimate adjusted odds ratios, average marginal effects, and predicted probabilities based on baseline exposures. Results Among patients with complete baseline and 8-year follow-up data, 59.9% died, 8.8% became frail, 2.4% were bedridden, and 28.9% remained non-frail. Longer dialysis duration and baseline frailty or bedridden status were associated with increased odds of subsequent frailty, bedridden status, and mortality. Compared with patients with Conclusions and Relevance In this nationwide 8-year study, majority of the hemodialysis patients experienced either death or functional decline. Longer dialysis duration and baseline frailty were associated with adverse outcomes, although absolute increases in frailty were modest. These findings highlight the need for early, values-based shared decision-making in the management of dialysis patients.
Open AccessImpact of Dialysis Duration and Frailty on Frailty Progression: A Japanese Nationwide Cohort Study
Importance Frailty is common among dialysis patients and significantly affects the quality of life for both patients and their caregivers. However, limited evidence exists on the long- term changes in physical function in this population. Objective To examine 8-year trajectories of physical function and assess associations with baseline dialysis duration and physical function status among Japanese dialysis patients. Design Nationwide, cohort study. Setting Japan; data obtained from a registry. Participants 223,501 Japanese adults receiving hemodialysis enrolled in the 2010 Japanese Society for Dialysis Therapy Renal Data Registry. Exposures Baseline dialysis duration (Main Outcomes and Measures Physical function at 8 years was similarly classified as non- frail, frail, bedridden, or deceased. Multinomial logistic regression was used to estimate adjusted odds ratios, average marginal effects, and predicted probabilities based on baseline exposures. Results Among patients with complete baseline and 8-year follow-up data, 59.9% died, 8.8% became frail, 2.4% were bedridden, and 28.9% remained non-frail. Longer dialysis duration and baseline frailty or bedridden status were associated with increased odds of subsequent frailty, bedridden status, and mortality. Compared with patients with Conclusions and Relevance In this nationwide 8-year study, majority of the hemodialysis patients experienced either death or functional decline. Longer dialysis duration and baseline frailty were associated with adverse outcomes, although absolute increases in frailty were modest. These findings highlight the need for early, values-based shared decision-making in the management of dialysis patients.
- Open Access
Shared Decision-Making in Renal Replacement Therapy Selection: Patient Perceptions, Preferences, and Influencing Factors in a Nationwide Cross-Sectional Study in Japan
Background: Shared decision-making (SDM) is a key process in selecting renal replacement therapy (RRT). This study analyzed SDM perceptions, preferences, and patient- and facility-level factors influencing SDM among Japanese patients with chronic kidney disease (CKD) who selected RRT. Methods: We analyzed 475 adult patients with CKD from 49 medical facilities. SDM awareness and recognition, preferences for SDM timing and frequency, discussion content, and desired professional involvement were assessed. Patient- and facility-level factors associated with SDM perceptions were evaluated using Poisson regression with cluster-robust variance estimation. Results: The mean age of participants was 67.4 years. Overall, 71%, 24.4%, and 4.4% chose hemodialysis, peritoneal dialysis, and kidney transplantation, respectively. While 81.2% perceived that SDM was performed during RRT selection, only 4.7% were explicitly aware of the concept. Patients prioritized discussions about effects on daily life, financial burden, and family-related concerns. Most preferred SDM initiation when RRT was imminent, conducted over multiple sessions. Many patients valued the involvement of medical social workers and their usual non-nephrologist physicians in addition to nephrologists. Multiple outpatient visits for RRT selection, involving nurse participation and extended consultation times, were significantly associated with SDM perceptions (prevalence ratio: 1.59, 95% confidence interval: 1.05–2.42). Conclusions: Many Japanese patients with CKD perceived SDM during RRT selection; however, they had limited awareness of the concept. The findings underscore the importance of establishing a system that facilitates repeated SDM discussions at critical moments for patients. These discussions should emphasize the impact of RRT on patients’ lives and involve a multidisciplinary team.
Open AccessShared Decision-Making in Renal Replacement Therapy Selection: Patient Perceptions, Preferences, and Influencing Factors in a Nationwide Cross-Sectional Study in Japan
Background: Shared decision-making (SDM) is a key process in selecting renal replacement therapy (RRT). This study analyzed SDM perceptions, preferences, and patient- and facility-level factors influencing SDM among Japanese patients with chronic kidney disease (CKD) who selected RRT. Methods: We analyzed 475 adult patients with CKD from 49 medical facilities. SDM awareness and recognition, preferences for SDM timing and frequency, discussion content, and desired professional involvement were assessed. Patient- and facility-level factors associated with SDM perceptions were evaluated using Poisson regression with cluster-robust variance estimation. Results: The mean age of participants was 67.4 years. Overall, 71%, 24.4%, and 4.4% chose hemodialysis, peritoneal dialysis, and kidney transplantation, respectively. While 81.2% perceived that SDM was performed during RRT selection, only 4.7% were explicitly aware of the concept. Patients prioritized discussions about effects on daily life, financial burden, and family-related concerns. Most preferred SDM initiation when RRT was imminent, conducted over multiple sessions. Many patients valued the involvement of medical social workers and their usual non-nephrologist physicians in addition to nephrologists. Multiple outpatient visits for RRT selection, involving nurse participation and extended consultation times, were significantly associated with SDM perceptions (prevalence ratio: 1.59, 95% confidence interval: 1.05–2.42). Conclusions: Many Japanese patients with CKD perceived SDM during RRT selection; however, they had limited awareness of the concept. The findings underscore the importance of establishing a system that facilitates repeated SDM discussions at critical moments for patients. These discussions should emphasize the impact of RRT on patients’ lives and involve a multidisciplinary team.
- Open Access
Trust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: A cross-sectional study
Rationale & Objective Person-centered care (PCC) and trust in physicians influence medication adherence (MA) among patients undergoing dialysis. However, the mechanisms linking PCC to MA, particularly the mediating effect of trust in physicians, remain unclear. This study aimed to investigate the interrelationships between PCC, trust in physicians, and MA. Study Design Multicenter cross-sectional study. Setting & Participants Japanese adults receiving outpatient hemodialysis at six dialysis centers. Exposures PCC was assessed using the 13-item Japanese Primary Care Assessment Tool-Short Form, which included longitudinality and coordination of care. Trust in physicians was measured using the five-item Wake Forest Physician Trust Scale. Outcome MA was measured using the 12-item Adherence Starts Knowledge (ASK-12) scale. Analytical Approach General linear models were used to examine the relationships between PCC, trust in physicians, and MA. Mediation analysis determined the extent to which trust in physicians mediated the PCC-MA relationship. Results In total, 483 patients were analyzed. High-quality PCC was associated with lower barriers to MA in a dose-response manner across JPCAT-SF quartiles compared to no usual source of care (Q1: −3.90 (95% CI: −5.95 to −1.75); Q2: −4.78 (95% confidence interval [CI]: −7.02 to −2.69); Q3: −4.69 (95% CI: −6.96 to −2.58); Q4: −4.95 (95% CI: −7.21 to −2.62). Trust in physicians partially mediated this relationship in a dose-response pattern, with the proportion of the indirect effect increasing from 16.1% (95% CI: 4.5 to 33.8%) in Q2 to 33.3% (95% CI: 17.4 to 65.5%) in Q4. Similar findings were observed for PCC subdomains. Limitation Possible reverse causation. Conclusions High-quality PCC was associated with MA, with trust in physicians playing a key mediating role. Strategies to enhance MA in patients undergoing hemodialysis should incorporate multidimensional PCC approaches, focusing on building trust and strengthening continuity and coordination of care.
Open AccessTrust in physicians as a mediator of the relationship between person-centered care and medication adherence in patients undergoing hemodialysis: A cross-sectional study
Rationale & Objective Person-centered care (PCC) and trust in physicians influence medication adherence (MA) among patients undergoing dialysis. However, the mechanisms linking PCC to MA, particularly the mediating effect of trust in physicians, remain unclear. This study aimed to investigate the interrelationships between PCC, trust in physicians, and MA. Study Design Multicenter cross-sectional study. Setting & Participants Japanese adults receiving outpatient hemodialysis at six dialysis centers. Exposures PCC was assessed using the 13-item Japanese Primary Care Assessment Tool-Short Form, which included longitudinality and coordination of care. Trust in physicians was measured using the five-item Wake Forest Physician Trust Scale. Outcome MA was measured using the 12-item Adherence Starts Knowledge (ASK-12) scale. Analytical Approach General linear models were used to examine the relationships between PCC, trust in physicians, and MA. Mediation analysis determined the extent to which trust in physicians mediated the PCC-MA relationship. Results In total, 483 patients were analyzed. High-quality PCC was associated with lower barriers to MA in a dose-response manner across JPCAT-SF quartiles compared to no usual source of care (Q1: −3.90 (95% CI: −5.95 to −1.75); Q2: −4.78 (95% confidence interval [CI]: −7.02 to −2.69); Q3: −4.69 (95% CI: −6.96 to −2.58); Q4: −4.95 (95% CI: −7.21 to −2.62). Trust in physicians partially mediated this relationship in a dose-response pattern, with the proportion of the indirect effect increasing from 16.1% (95% CI: 4.5 to 33.8%) in Q2 to 33.3% (95% CI: 17.4 to 65.5%) in Q4. Similar findings were observed for PCC subdomains. Limitation Possible reverse causation. Conclusions High-quality PCC was associated with MA, with trust in physicians playing a key mediating role. Strategies to enhance MA in patients undergoing hemodialysis should incorporate multidimensional PCC approaches, focusing on building trust and strengthening continuity and coordination of care.
- Open Access
Combined pre-dialysis systolic blood pressure and pulse rate assessment for all-cause and cardiovascular mortalities: A nationwide cohort study on patients undergoing haemodialysis
Background and Aims: The prognostic utility of the combined assessment of pre-haemodialysis systolic blood pressure (SBP) and pulse rate (PR) compared with their individual assessment is unclear. This study aimed to determine whether the combined assessment could enhance the prognostic utility in patients on haemodialysis. Methods: This nationwide cohort study involved patients undergoing maintenance haemodialysis using the Japanese Renal Data Registry database. Exposure was defined as a combination of SBP and PR. Forty-eight levels of exposure groups were created: SBP (six levels; P P <0.002, respectively). A lower SBP was associated with a higher risk of all-cause mortality regardless of the PR. Most categories of lower SBP or higher PR vs. the 120-<140 mmHg and 70-<80/min category had positive RERIs. Similar findings were also observed for cardiac mortality. Conclusions: The combined assessment of pre-dialysis SBP and PR may help in the simple stratification of patients with excess risks that cannot be identified by individual SBP or PR assessment.
Open AccessCombined pre-dialysis systolic blood pressure and pulse rate assessment for all-cause and cardiovascular mortalities: A nationwide cohort study on patients undergoing haemodialysis
Background and Aims: The prognostic utility of the combined assessment of pre-haemodialysis systolic blood pressure (SBP) and pulse rate (PR) compared with their individual assessment is unclear. This study aimed to determine whether the combined assessment could enhance the prognostic utility in patients on haemodialysis. Methods: This nationwide cohort study involved patients undergoing maintenance haemodialysis using the Japanese Renal Data Registry database. Exposure was defined as a combination of SBP and PR. Forty-eight levels of exposure groups were created: SBP (six levels; P P <0.002, respectively). A lower SBP was associated with a higher risk of all-cause mortality regardless of the PR. Most categories of lower SBP or higher PR vs. the 120-<140 mmHg and 70-<80/min category had positive RERIs. Similar findings were also observed for cardiac mortality. Conclusions: The combined assessment of pre-dialysis SBP and PR may help in the simple stratification of patients with excess risks that cannot be identified by individual SBP or PR assessment.
- Open Access
- 2 February 2024
- Published by S. Karger AG in Cardiorenal Medicine
- Vol. 14 (1) , 1
Impact of dysmagnesemia on atrial fibrillation in maintenance hemodialysis patients: a nationwide study
Introduction: The dose-response relationship between serum magnesium (sMg) and atrial fibrillation (AF) and the contribution of dysmagnesemia to AF among hemodialysis patients remain unknown. Hence, we examined the dose-response correlation between sMg and AF and estimated the extent of the contribution of dysmagnesemia to AF in this population. Methods: This was a nationwide cross-sectional study on the Japanese Society for Dialysis Therapy registry, also known as Japanese Renal Data Registry (JRDR), encompassing a nationwide population of dialysis centers, as of the end of 2019. Eligible participants were adult patients undergoing hemodialysis three times per week. The main exposure was sMg, categorized into seven categories (≤1.5, >1.5–≤2, >2–≤2.5, >2.5–≤3, >3–≤3.5, >3.5–≤4, and ≥4.0 mg/dL). The outcome was AF reported by dialysis facilities. The independent contribution to AF was assessed via logistic regression to generate population-attributable fractions, assuming a causal relationship between sMg and AF. Results: Total 165,926 patients from 2,549 facilities were investigated. AF prevalence was 7.9%. Compared with the reference (>2.5–≤3 mg/dL), lower sMg was associated with increased AF (adjusted odds ratios [ORs] [95% confidence interval, CI] of 1.49 [1.19–1.85], 1.24 [1.17–1.32], and 1.11 [1.06–1.16] for sMg of ≤1.5, >1.5–≤2.0, and >2.0–≤2.5 mg/dL categories, respectively). Elevated sMg was associated with fewer AF (adjusted OR 0.87 [95% CI, 0.79–0.96] for sMg of >3.0–≤3.5 mg/dL). The adjusted population-attributable fraction of lower sMg and higher and lower sMg for AF was 7.4% and 6.9%, respectively. An association did indeed exist between lower sMg and AF, with the lowest percentages of AF at sMg levels above the reference range for the general population. Conclusion: Dysmagnesemia may be an important contributor to AF among adult hemodialysis patients. Further longitudinal studies are warranted to determine whether sMg correction reduces the AF incidence.
- 2 February 2024
- Published by S. Karger AG in Cardiorenal Medicine
- Vol. 14 (1) , 1
Open AccessImpact of dysmagnesemia on atrial fibrillation in maintenance hemodialysis patients: a nationwide study
Introduction: The dose-response relationship between serum magnesium (sMg) and atrial fibrillation (AF) and the contribution of dysmagnesemia to AF among hemodialysis patients remain unknown. Hence, we examined the dose-response correlation between sMg and AF and estimated the extent of the contribution of dysmagnesemia to AF in this population. Methods: This was a nationwide cross-sectional study on the Japanese Society for Dialysis Therapy registry, also known as Japanese Renal Data Registry (JRDR), encompassing a nationwide population of dialysis centers, as of the end of 2019. Eligible participants were adult patients undergoing hemodialysis three times per week. The main exposure was sMg, categorized into seven categories (≤1.5, >1.5–≤2, >2–≤2.5, >2.5–≤3, >3–≤3.5, >3.5–≤4, and ≥4.0 mg/dL). The outcome was AF reported by dialysis facilities. The independent contribution to AF was assessed via logistic regression to generate population-attributable fractions, assuming a causal relationship between sMg and AF. Results: Total 165,926 patients from 2,549 facilities were investigated. AF prevalence was 7.9%. Compared with the reference (>2.5–≤3 mg/dL), lower sMg was associated with increased AF (adjusted odds ratios [ORs] [95% confidence interval, CI] of 1.49 [1.19–1.85], 1.24 [1.17–1.32], and 1.11 [1.06–1.16] for sMg of ≤1.5, >1.5–≤2.0, and >2.0–≤2.5 mg/dL categories, respectively). Elevated sMg was associated with fewer AF (adjusted OR 0.87 [95% CI, 0.79–0.96] for sMg of >3.0–≤3.5 mg/dL). The adjusted population-attributable fraction of lower sMg and higher and lower sMg for AF was 7.4% and 6.9%, respectively. An association did indeed exist between lower sMg and AF, with the lowest percentages of AF at sMg levels above the reference range for the general population. Conclusion: Dysmagnesemia may be an important contributor to AF among adult hemodialysis patients. Further longitudinal studies are warranted to determine whether sMg correction reduces the AF incidence.